srt1720 group Search Results


srt1720 group  (MedChemExpress)
95
MedChemExpress srt1720 group
Srt1720 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/srt1720+group/SRT+1720/pm40846953-73-103-113
Average 95 stars, based on 1 article reviews
srt1720 group - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
sirt1 agonist srt1720  (Selleck Chemicals)
95
Selleck Chemicals sirt1 agonist srt1720
Real-time PCR primer sequences
Sirt1 Agonist Srt1720, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/srt1720+group/SRT1720+HCl/pmc07105640-96-27-34
Average 95 stars, based on 1 article reviews
sirt1 agonist srt1720 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

Image Search Results


Real-time PCR primer sequences

Journal: Obesity Facts

Article Title: Acupuncture Targeting SIRT1 in the Hypothalamic Arcuate Nucleus Can Improve Obesity in High-Fat-Diet-Induced Rats with Insulin Resistance via an Anorectic Effect

doi: 10.1159/000503752

Figure Lengend Snippet: Real-time PCR primer sequences

Article Snippet: At the same time of treatment in the EA group, we intracerebroventricularly injected rats in the SO group with ASCF, rats in the AG group with the SIRT1 agonist SRT1720 (1 μg/μL, 2 μL; Selleck, US) [ 35 ], and rats in the EA + AN group with the SIRT1 antagonist EX-527 (1 μg/μL, 5 μL; Selleck) before EA treatment (Fig. ) [ 36 ].

Techniques: Real-time Polymerase Chain Reaction

A–J Protein expression and relative mRNA levels of SIRT1, FOXO1, Ac-FOXO1, POMC, and NPY in the hypothalamus. * p< 0.05, ** p< 0.01, vs. NG; # p< 0.05, ## p< 0.01, vs. MG; Δ p< 0.05, ΔΔ p< 0.01, vs. EA. SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y.

Journal: Obesity Facts

Article Title: Acupuncture Targeting SIRT1 in the Hypothalamic Arcuate Nucleus Can Improve Obesity in High-Fat-Diet-Induced Rats with Insulin Resistance via an Anorectic Effect

doi: 10.1159/000503752

Figure Lengend Snippet: A–J Protein expression and relative mRNA levels of SIRT1, FOXO1, Ac-FOXO1, POMC, and NPY in the hypothalamus. * p< 0.05, ** p< 0.01, vs. NG; # p< 0.05, ## p< 0.01, vs. MG; Δ p< 0.05, ΔΔ p< 0.01, vs. EA. SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y.

Article Snippet: At the same time of treatment in the EA group, we intracerebroventricularly injected rats in the SO group with ASCF, rats in the AG group with the SIRT1 agonist SRT1720 (1 μg/μL, 2 μL; Selleck, US) [ 35 ], and rats in the EA + AN group with the SIRT1 antagonist EX-527 (1 μg/μL, 5 μL; Selleck) before EA treatment (Fig. ) [ 36 ].

Techniques: Expressing

Double-labeled immunofluorescence of SIRT1/FOXO1 (A), SIRT1/Ac-FOXO1 (B), FOXO1/POMC (C), and Ac-FOXO1/NPY (D) in hypothalamic ARC (* p < 0.05, ** p < 0.01, vs. NG; # p< 0.05, ## p< 0.01, vs. MG; Δ p< 0.05, ΔΔ p< 0.01, vs. EA). SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y; ARC, arcuate nucleus.

Journal: Obesity Facts

Article Title: Acupuncture Targeting SIRT1 in the Hypothalamic Arcuate Nucleus Can Improve Obesity in High-Fat-Diet-Induced Rats with Insulin Resistance via an Anorectic Effect

doi: 10.1159/000503752

Figure Lengend Snippet: Double-labeled immunofluorescence of SIRT1/FOXO1 (A), SIRT1/Ac-FOXO1 (B), FOXO1/POMC (C), and Ac-FOXO1/NPY (D) in hypothalamic ARC (* p < 0.05, ** p < 0.01, vs. NG; # p< 0.05, ## p< 0.01, vs. MG; Δ p< 0.05, ΔΔ p< 0.01, vs. EA). SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y; ARC, arcuate nucleus.

Article Snippet: At the same time of treatment in the EA group, we intracerebroventricularly injected rats in the SO group with ASCF, rats in the AG group with the SIRT1 agonist SRT1720 (1 μg/μL, 2 μL; Selleck, US) [ 35 ], and rats in the EA + AN group with the SIRT1 antagonist EX-527 (1 μg/μL, 5 μL; Selleck) before EA treatment (Fig. ) [ 36 ].

Techniques: Labeling, Immunofluorescence

Mechanisms by which EA affects in the network between the nuclei of the CNS and so regulates food intake. SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y; α-MSH, α-melanocyte-stimulating hormone; AgRP, agouti-related protein; MC4R, melanocortin receptor 4; TRH, thyrotropin-releasing hormone; CRH, corticotropin releasing hormone; ORX, orexin; MCH, melanin concentrating hormone; PVN, paraventricular nucleus; LHA, lateral hypothalamic area; ARC, arcuate nucleus.

Journal: Obesity Facts

Article Title: Acupuncture Targeting SIRT1 in the Hypothalamic Arcuate Nucleus Can Improve Obesity in High-Fat-Diet-Induced Rats with Insulin Resistance via an Anorectic Effect

doi: 10.1159/000503752

Figure Lengend Snippet: Mechanisms by which EA affects in the network between the nuclei of the CNS and so regulates food intake. SIRT1, silent mating type information regulation 2 homolog 1; FOXO1, forkhead box protein O1; Ac-FOXO1, acetylated FOXO1; NPY, neuropeptide Y; α-MSH, α-melanocyte-stimulating hormone; AgRP, agouti-related protein; MC4R, melanocortin receptor 4; TRH, thyrotropin-releasing hormone; CRH, corticotropin releasing hormone; ORX, orexin; MCH, melanin concentrating hormone; PVN, paraventricular nucleus; LHA, lateral hypothalamic area; ARC, arcuate nucleus.

Article Snippet: At the same time of treatment in the EA group, we intracerebroventricularly injected rats in the SO group with ASCF, rats in the AG group with the SIRT1 agonist SRT1720 (1 μg/μL, 2 μL; Selleck, US) [ 35 ], and rats in the EA + AN group with the SIRT1 antagonist EX-527 (1 μg/μL, 5 μL; Selleck) before EA treatment (Fig. ) [ 36 ].

Techniques: